Carregant...

Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis

Background: Sarcoidosis goes into remission in two-thirds of patients with sarcoidosis, but about 20 % of patients develop pulmonary fibrosis. The mechanisms of pulmonary fibrosis in sarcoidosis and differences in pathogenesis between clinical stages are still unclear. Objectives: The aim of this st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sarcoidosis Vasc Diffuse Lung Dis
Autors principals: Nukui, Yoshihisa, Miyazaki, Yasunari, Suhara, Kozo, Okamoto, Tsukasa, Furusawa, Haruhiko, Inase, Naohiko
Format: Artigo
Idioma:Inglês
Publicat: Mattioli 1885 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170057/
https://ncbi.nlm.nih.gov/pubmed/32476874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36141/svdld.v35i1.5834
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!